retatrutide clinical studies (GLP-3) Results: What Trials Actually Show retatrutide clinical trial data trials

Kushner, for joining us today

Without copper delivered in this controlled manner, these enzymatic processes slow down

Hypoglycaemia (low blood sugar levels) GLP-1 RAs are glucose-dependent stimulators of insulin, meaning they shouldnt cause dangerous hypoglycemia on their own in a healthy person (unlike taking insulin)

Lemmens G, Van Camp A, Kourula S, Vanuytsel T, Augustijns P (2021) Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring

3.1.2 Hepatic First-Pass Metabolism Even if a small amount of GSH enters the bloodstream, it will be quickly taken up and metabolized by the liver

This will lead to more CGM exposure and use in primary care practices